Health care firm expands with acquisition worth at least $125M

Fort Myers-baed NeoGenomics purchases Genoptix of Carlsbad, Calif., to expand its footprint into oncology practices.

  • By Business Observer Staff
  • | 5:30 a.m. December 13, 2018
  • | 0 Free Articles Remaining!
NeoGenomics chairman and CEO Douglas VanOort
NeoGenomics chairman and CEO Douglas VanOort
  • Charlotte–Lee–Collier
  • Share

FORT MYERS —  NeoGenomics, a cancer-focused genetic testing services firm headquartered in Fort Myers, has completed the acquisition of the parent company of Genoptix Inc. of Carlsbad, Calif.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • February 5, 2026
After changes, Boar’s Head reopens plant tied to listeria outbreak
  • February 5, 2026
Naples' David Hoffmann takes over Iowa newspaper chain
  • February 5, 2026
Tampa Bay Rays unveil stadium designs, plan to woo public
  • February 5, 2026
Lakeland man to pay $12.9M, go to prison for filing 450 fake tax returns

Sponsored Content